Uri Nir

1.6k total citations
56 papers, 1.3k citations indexed

About

Uri Nir is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Uri Nir has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Genetics. Recurrent topics in Uri Nir's work include Sperm and Testicular Function (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Epigenetics and DNA Methylation (7 papers). Uri Nir is often cited by papers focused on Sperm and Testicular Function (8 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Epigenetics and DNA Methylation (7 papers). Uri Nir collaborates with scholars based in Israel, United States and Canada. Uri Nir's co-authors include Sally Shpungin, Eitan Friedman, Asaf Levy, Michael Korostishevsky, Shai Bel, Eli Keshet, Ahuva Itin, William J. Rutter, Jeffrey C. Edman and Gregory M. Shackleford and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Uri Nir

55 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uri Nir Israel 21 860 288 182 181 138 56 1.3k
Kenta Masuda Japan 25 896 1.0× 496 1.7× 278 1.5× 236 1.3× 141 1.0× 77 1.7k
David M. Kaetzel United States 25 1.2k 1.4× 115 0.4× 248 1.4× 157 0.9× 148 1.1× 60 1.7k
Lluís López-Barcons United States 16 742 0.9× 186 0.6× 305 1.7× 79 0.4× 136 1.0× 44 1.3k
Jianping Zheng China 20 727 0.8× 403 1.4× 288 1.6× 142 0.8× 78 0.6× 37 1.4k
Stéphane Gobeil Canada 19 1.1k 1.3× 349 1.2× 246 1.4× 136 0.8× 200 1.4× 33 1.6k
Joan Riley United Kingdom 16 620 0.7× 196 0.7× 199 1.1× 96 0.5× 69 0.5× 44 1.0k
Nameer B. Kirma United States 22 593 0.7× 286 1.0× 402 2.2× 357 2.0× 274 2.0× 63 1.4k
Catherine J. Huntoon United States 22 857 1.0× 234 0.8× 536 2.9× 136 0.8× 386 2.8× 30 1.4k
Balraj Singh United States 24 989 1.1× 426 1.5× 824 4.5× 328 1.8× 192 1.4× 71 2.0k
Muthu Selvakumaran United States 22 1.3k 1.5× 339 1.2× 745 4.1× 118 0.7× 233 1.7× 31 1.9k

Countries citing papers authored by Uri Nir

Since Specialization
Citations

This map shows the geographic impact of Uri Nir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Nir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Nir more than expected).

Fields of papers citing papers by Uri Nir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Nir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Nir. The network helps show where Uri Nir may publish in the future.

Co-authorship network of co-authors of Uri Nir

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Nir. A scholar is included among the top collaborators of Uri Nir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Nir. Uri Nir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nir, Uri, et al.. (2023). Fer and FerT: A New Regulatory Link between Sperm and Cancer Cells. International Journal of Molecular Sciences. 24(6). 5256–5256. 3 indexed citations
2.
Shpungin, Sally, et al.. (2022). The Fer tyrosine kinase protects sperm from spontaneous acrosome reaction. Developmental Biology. 487. 24–33. 2 indexed citations
3.
Varvak, Alexander, et al.. (2014). Oncogenic Properties of a Spermatogenic Meiotic Variant of Fer Kinase Expressed in Somatic Cells. Cancer Research. 74(22). 6474–6485. 9 indexed citations
4.
Shpungin, Sally, et al.. (2012). Down-regulation of Fer induces ROS levels accompanied by ATM and p53 activation in colon carcinoma cells. Cellular Signalling. 24(7). 1369–1374. 13 indexed citations
5.
Okun, Eitan, et al.. (2009). Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells. Leukemia & lymphoma. 50(4). 625–632. 23 indexed citations
6.
Levy, Asaf, et al.. (2009). Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high‐risk women. International Journal of Cancer. 127(3). 589–597. 103 indexed citations
7.
Frydman, Moshe, et al.. (2008). Deleterious Mutations in the Zinc-Finger 469 Gene Cause Brittle Cornea Syndrome. The American Journal of Human Genetics. 82(5). 1217–1222. 95 indexed citations
8.
Cohen, Shimrit, Yael Laitman, Bella Kaufman, et al.. (2008). SULT1E1 and ID2 genes as candidates for inherited predisposition to breast and ovarian cancer in Jewish women. Familial Cancer. 8(2). 135–144. 5 indexed citations
9.
Cohen, Yoram, et al.. (2008). Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers. Breast Cancer Research and Treatment. 116(1). 195–200. 38 indexed citations
10.
Albeck, Michael, et al.. (2007). Novel Involvement of the Immunomodulator AS101 in IL‐10 Signaling, via the Tyrosine Kinase Fer. Annals of the New York Academy of Sciences. 1095(1). 240–250. 9 indexed citations
11.
Shpungin, Sally, et al.. (2006). trnp: A Conserved Mammalian Gene Encoding a Nuclear Protein That Accelerates Cell-Cycle Progression. DNA and Cell Biology. 25(6). 331–339. 15 indexed citations
12.
Shpungin, Sally, et al.. (2004). Fer kinase sustains the activation level of ERK1/2 and increases the production of VEGF in hypoxic cells. Cellular Signalling. 17(3). 341–353. 16 indexed citations
13.
Shpungin, Sally, et al.. (2003). Fer Is a Downstream Effector of Insulin and Mediates the Activation of Signal Transducer and Activator of Transcription 3 in Myogenic Cells. Molecular Endocrinology. 17(8). 1580–1592. 13 indexed citations
14.
Dagon, Yossi, Sara Dovrat, Dalia Hacohen, et al.. (2001). Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells. Oncogene. 20(56). 8045–8056. 21 indexed citations
15.
Beery, Rachel, Michal Haimsohn, Rina Hemi, et al.. (2001). Activation of the Insulin-Like Growth Factor 1 Signaling Pathway by the Antiapoptotic Agents Aurintricarboxylic Acid and Evans Blue1. Endocrinology. 142(7). 3098–3107. 36 indexed citations
16.
Ben‐Dor, Israel, et al.. (2000). FER Kinase Activation of Stat3 Is Determined by the N-terminal Sequence. Journal of Biological Chemistry. 275(37). 28902–28910. 27 indexed citations
17.
Carmel, Miri, Sally Shpungin, & Uri Nir. (2000). Role of positive and negative regulation in modulation of the Fer promoter activity. Gene. 241(1). 87–99. 2 indexed citations
18.
Ben‐Dor, Israel, et al.. (1998). Tyrosine phosphorylation of the TATA element modulatory factor by the FER nuclear tyrosine kinases. FEBS Letters. 434(3). 339–345. 17 indexed citations
19.
Navon, Ami, et al.. (1994). Meiosis-dependent tyrosine phosphorylation of a yeast protein related to the mouse p51ferT. Molecular and General Genetics MGG. 244(2). 160–167. 5 indexed citations
20.
Edman, Jeffrey C., et al.. (1990). A Murine fer Testis-Specific Transcript ( ferT) Encodes a Truncated Fer Protein. Molecular and Cellular Biology. 10(1). 146–153. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenta Masuda Breakdown of academic impact, for papers by David M. Kaetzel Breakdown of academic impact, for papers by Lluís López-Barcons Breakdown of academic impact, for papers by Jianping Zheng Breakdown of academic impact, for papers by Stéphane Gobeil Breakdown of academic impact, for papers by Joan Riley Breakdown of academic impact, for papers by Nameer B. Kirma Breakdown of academic impact, for papers by Catherine J. Huntoon Breakdown of academic impact, for papers by Balraj Singh Breakdown of academic impact, for papers by Muthu Selvakumaran
Rankless by CCL
2026